Replies to post #524713 on NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Here’s the fly in the ointment. Management has ostensibly restricted the information it provides to shareholders, well beyond what’s considered reasonable for a public company. And I might add, what’s necessary to make well informed investment decisions.

But we can make well informed, intelligent decisions based on the FACTS we have from DD, and not rumor or pure speculatio

I would proffer that the lack of information has led to investors making decisions on faith rather than fact, and has scared away institutional investors for that reason. Any small shred of “evidence” that favors buying NWBO could easily be followed by an entire basket of negative information that could bring down the house. We just don’t know and have very little information to weigh the risks and rewards. Owning this stock is now pure speculation. Nothing more; nothing less.

And that falls on the shoulders of LP and LG.

[ilovetech]

I agree. I see no rationale for BP to remain idle if there's serious interest. You want the asset under your control as soon as possible, unless there are some prerequisites needing buttoning down, i.e. Flashworks perhaps, certainly at least an approval. With that said, paperwork should be in place awaiting for the key milestone(s) to occur. Beyond that, I don't find a reasonable argument for BP and NWBO to diddle daddle for some time horizon to come and go. BP's are way too big and accountable to their stakeholders to be in the business of toe dipping, assuming they've seen what they want which validates the target acquisition.

ILT